When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Pfizer–BioNTech COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Pfizer–BioNTech_COVID-19...

   The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.

3. Operation Warp Speed - Wikipedia

   en.wikipedia.org/wiki/Operation_Warp_Speed

   On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).

4. COVID-19 vaccination in the United States - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in...

   The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.

5. CDC recommends Pfizer/BioNTech boosters for certain ... - AOL

   www.aol.com/finance/cdc-advisory-panel-votes...

   A CDC advisory panel voted Thursday to recommend COVID-19 boosters of the Pfizer/BioNTech vaccine for a broad population of U.S. residents. The CDC released guidance that overruled the panel.

6. Over half of vaccine boosters administered are Pfizer. See ...

   www.aol.com/news/map-pfizer-boosters-dominate-u...

   The Pfizer-BioNTech Covid vaccine booster accounts for about 55 percent of all booster shots in the U.S., according to an NBC News analysis of CDC data.

7. U.S. weighing shorter timeline for COVID booster shots, says ...

   www.aol.com/finance/biden-says-discussing...

   The Wall Street Journal on Wednesday said U.S. regulators could approve a third COVID-19 shot of the two-dose Moderna Inc and Pfizer Inc-BioNTech AG beginning at least six months after full ...

8. mRNA vaccine - Wikipedia

   en.wikipedia.org/wiki/MRNA_vaccine

   The COVID-19 mRNA vaccines from Moderna and Pfizer–BioNTech had short-term efficacy rates of over 90 percent against the original SARS-CoV-2 virus. Prior to mRNA, drug trials on pathogens other than COVID-19 were not effective and had to be abandoned in the early phases of trials. The reason for the efficacy of the new mRNA vaccines is not clear.

9. Pfizer, BioNTech Rise As Phase 2/3 Covid-19 Vaccine Trial ...

   www.aol.com/news/pfizer-biontech-rise-phase-2...

   Pfizer (PFE) and BioNTech SE (BNTX) have announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA ...